Stock LTRN LANTERN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Real-time Estimate Cboe BZX
Other stock markets
 11:09:13 2024-05-20 am EDT 		5-day change 1st Jan Change
5.755 USD -4.56% Intraday chart for Lantern Pharma Inc. -5.58% +34.35%
May. 09 Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Starts Lantern Pharma at Neutral
MT
EF Hutton Starts Lantern Pharma at Buy With $11 Price Target
MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating
MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $34 From $32, Keeps Buy Rating
MT
LANTERN PHARMA : HC Wainwright Starts Lantern Pharma at Buy with $32 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LTRN Stock
  4. News Lantern Pharma Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW